InDex Pharmaceuticals Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 7
Employees
  • Stock Symbol
  • INDEX
Stock Symbol
  • Share Price
  • $0.18
  • (As of Wednesday Closing)

InDex Pharmaceuticals General Information

Description

InDex Pharmaceuticals Holding AB is a pharmaceutical development company focusing on immunological diseases where there is an unmet medical need for new treatment options. Its portfolio includes cobitolimod and colitis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Berzelius väg 13
  • 171 65 Solna
  • Sweden
+46 08-508 000 00

InDex Pharmaceuticals Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InDex Pharmaceuticals Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.18 $0.17 $0.13 - $0.41 $94.8M 533M 668K

InDex Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 97,348 43,354 43,256 40,740
Revenue 2 4 9 15
EBITDA (4,650) (6,091) (9,174) (9,323)
Net Income (4,803) (6,227) (9,280) (9,441)
Total Assets 61,556 7,459 13,807 9,614
Total Debt 238 285 52 159
Public Fundamental Data provided by Morningstar, Inc. disclaimer

InDex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InDex Pharmaceuticals‘s full profile, request access.

Request a free trial

InDex Pharmaceuticals Executive Team (8)

Name Title Board Seat Contact Info
Peter Zerhouni Chief Executive Officer
Johan Giléus Chief Financial Officer
Pernilla Sandwall Chief Operating Officer
Per-Olof Gunnesson Vice President, Business Development
Thomas Knittel MD Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

InDex Pharmaceuticals Board Members (6)

Name Representing Role Since
Lennart Hansson Self Board Member 000 0000
Stig Pedersen Self Board Member 000 0000
You’re viewing 2 of 6 board members. Get the full list »

InDex Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InDex Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore InDex Pharmaceuticals‘s full profile, request access.

Request a free trial